Day One Biopharmaceuticals, Inc. (DAWN) DCF Valuation

Day One Biopharmaceuticals, Inc. (DAWN) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Day One Biopharmaceuticals, Inc. (DAWN) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify Day One Biopharmaceuticals, Inc. (DAWN) valuation with this customizable DCF Calculator! Featuring real Day One Biopharmaceuticals, Inc. (DAWN) financials and adjustable forecast inputs, you can test scenarios and uncover Day One Biopharmaceuticals, Inc. (DAWN) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA .0 -43.7 -72.6 -141.7 -206.1 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 14.9 .2 .2 .5 .4 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -14.9 -43.8 -72.8 -142.2 -206.4 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 27.3 43.7 284.3 342.3 366.3 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .1 .2 1.7 .3 2.6 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 -.1 -8.0 .0 -3.2 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -12.9 -40.5 -70.4 -132.2 -206.4 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 2.1 -40.3 -76.7 -133.2 -207.0 -2.6 .0 .0 .0 .0
WACC, % 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39
PV UFCF
SUM PV UFCF -2.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -230
Equity Value 228
Diluted Shares Outstanding, MM 80
Equity Value Per Share 2.86

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real DAWN financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
  • Forecast Flexibility: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe how your inputs affect Day One Biopharmaceuticals’ valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Comprehensive Financial Data: Gain access to precise pre-loaded historical figures and future forecasts for Day One Biopharmaceuticals, Inc. (DAWN).
  • Tailored Forecast Inputs: Modify highlighted cells for key variables such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • Interactive Dashboard: User-friendly charts and summaries to effectively visualize your valuation outcomes.
  • Designed for All Levels: An easy-to-navigate layout suited for investors, CFOs, and consultants alike.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Day One Biopharmaceuticals, Inc.'s (DAWN) preloaded data.
  • 2. Adjust Assumptions: Modify key inputs such as growth projections, WACC, and capital investments.
  • 3. View Results Instantly: The DCF model automatically calculates the intrinsic value and NPV.
  • 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation possibilities.
  • 5. Utilize with Assurance: Present professional valuation insights to strengthen your decision-making process.

Why Choose This Calculator?

  • Designed for Experts: A specialized tool utilized by researchers, financial analysts, and industry leaders.
  • Accurate Data: Day One Biopharmaceuticals' (DAWN) historical and projected financials are preloaded for precision.
  • Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions.
  • Comprehensive Outputs: Instantly calculates intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance takes you through each stage of the process.

Who Should Use Day One Biopharmaceuticals, Inc. (DAWN)?

  • Investors: Gain insights into the biopharmaceutical sector with a comprehensive analysis tool tailored for informed decision-making.
  • Financial Analysts: Streamline your workflow with an intuitive model designed specifically for biotech evaluations.
  • Consultants: Easily modify the framework for impactful client presentations or detailed reports in the life sciences field.
  • Biotech Enthusiasts: Enhance your knowledge of drug development and market strategies through practical case studies.
  • Educators and Students: Utilize this resource as a hands-on learning aid in courses focused on biopharmaceutical finance.

What the Template Contains

  • Preloaded DAWN Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.